市場調查報告書
商品編碼
1467756
2024-2032 年按產品類型、應用、最終用途、最終用戶和地區分類的一次性生物加工市場報告Single-Use Bioprocessing Market Report by Product Type, Application, End-Use, End-User, and Region 2024-2032 |
IMARC Group年,全球一次性生物加工市場規模達到 161 億美元。慢性病盛行率的不斷上升、技術進步的不斷進步以及藥物和生物製劑批准數量的增加是推動市場發展的一些關鍵因素。
一次性生物加工技術旨在對一次性使用的生物製藥產品進行過濾、儲存、細胞培養、混合和純化。它具有成本效益、節省時間,並提供靈活性和無麻煩的處置。與傳統的生物處理相比,它透過消除複雜的步驟來幫助提高生產力,並降低個體之間交叉污染的風險。除此之外,與鋼鐵相比,它還利於減少能源、介質消耗和碳足跡,並提供永續的製造流程。它用於有效生產疫苗、植物細胞培養和單株抗體。由於它還減少了工作人員進行設定、驗證和記錄的時間,因此全球範圍內對一次性生物加工技術的需求正在增加。
目前,全球大眾中糖尿病、氣喘、關節炎、癌症、高血壓、心臟病、中風和慢性阻塞性肺病(COPD)等慢性病的盛行率不斷上升,這是支持成長的關鍵因素之一市場的。除此之外,由於世界各地藥品核准和生物製劑數量不斷增加,對一次性生物加工的需求不斷成長,這對市場產生了積極影響。此外,人們對高檔聚合物材料和塑膠複合材料製造的產品的偏好不斷提高,因為它們具有增強的整體強度,為行業投資者提供了利潤豐厚的成長機會。除此之外,一次性生物處理系統提供的各種好處,例如較低的勞動力、材料和投資成本,正在推動市場的成長。除此之外,各種技術進步的出現,例如人工智慧(AI)、機器學習(ML)和一次性生物處理中用於預測錯誤和提高準確性的巨量資料解決方案,正在推動市場的成長。此外,在製藥過程中,一次性生物加工在培養基製備和生物製劑運輸中的使用日益增多,這提供了良好的市場前景。與此一致的是,一次性生物加工的日益普及,因為與傳統生物加工相比,它減少了二氧化碳(CO2)的量,正在推動市場的成長。此外,由於全球醫療保健設施的改善,一次性生物加工的就業不斷增加,也促進了市場的成長。
The global single-use bioprocessing market size reached US$ 16.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.5 Billion by 2032, exhibiting a growth rate (CAGR) of 16.2% during 2024-2032. The growing prevalence of chronic diseases, increasing technological advancements, and rising number of drug approvals and biologics represent some of the key factors driving the market.
Single-use bioprocessing technology is designed for filtration, storage, cell culture, mixing, and purification of biopharmaceutical products for one-time use. It is cost-effective, timesaving, and provides flexibility and hassle-free disposal. It assists in increasing productivity by eliminating complex steps and reduces the risks of cross-contamination among individuals as compared to traditional bioprocessing. Besides this, it is beneficial in reducing energy, media consumption, and carbon footprint and providing a sustainable manufacturing process as compared to steel. It is utilized for the effective production of vaccines, plant cell cultivation, and monoclonal antibodies. As it also reduces the time of staff members for set-up, validation, and documentation, the demand for single-use bioprocessing technology is increasing across the globe.
Presently, the rising prevalence of chronic diseases, such as diabetes, asthma, arthritis, cancer, hypertension, heart attack, stroke, and chronic obstructive pulmonary disease (COPD), among the masses across the globe represents one of the key factors supporting the growth of the market. Apart from this, the growing demand for single-use bioprocessing due to the increasing number of drug approvals and biologics around the world is positively influencing the market. Additionally, rising preferences of products manufactured from high-grade polymer materials and plastic composites, as they offer enhanced integral strength, is offering lucrative growth opportunities to industry investors. Besides this, various benefits offered by single-use bioprocessing systems, such as lower labor, material, and investment costs, are propelling the growth of the market. In addition to this, the emergence of various technological advancements, such as artificial intelligence (AI), machine learning (ML), and big data solutions in single-use bioprocessing for predicting errors and improving accuracy, is bolstering the growth of the market. Moreover, the growing utilization of single-use bioprocessing in media preparation and shipping of biologics while manufacturing pharmaceuticals is offering a favorable market outlook. In line with this, the rising adoption of single-use bioprocessing, as it reduces the amount of carbon dioxide (CO2) compared to traditional bioprocessing, is impelling the growth of the market. Furthermore, the increasing employment of single-use bioprocessing due to the improving healthcare facilities across the globe is contributing to the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global single-use bioprocessing market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, application, end-use and, end-user.
Media Bags and Containers
Filtration Assemblies
Single-Use Bioreactors
Disposable Mixers
Others
The report has provided a detailed breakup and analysis of the single-use bioprocessing market based on the product type. This includes media bags and containers, filtration assemblies, single-use bioreactors, disposable mixers, and others. According to the report, media bags and containers represented the largest segment.
Filtration
Storage
Cell Culture
Mixing
Purification
A detailed breakup and analysis of the single-use bioprocessing market based on the application has also been provided in the report. This includes filtration, storage, cell culture, mixing, and purification. According to the report, filtration accounted for the largest market share.
Upstream
Fermentation
Downstream
A detailed breakup and analysis of the single-use bioprocessing market based on the end-use has also been provided in the report. This includes upstream, fermentation, and downstream. According to the report, upstream accounted for the largest market share.
Biopharmaceutical Manufacturers
Life Science R&D
Others
A detailed breakup and analysis of the single-use bioprocessing market based on the end-user has also been provided in the report. This includes biopharmaceutical manufacturers, life science R&D, and others. According to the report, biopharmaceutical manufacturers accounted for the largest market share.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Saudi Arabia
Iran
United Arab Emirates
Others
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, and others); and the Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, and others). According to the report, North America (the United States and Canada) was the largest market for single-use bioprocessing. Some of the factors driving the North America single-use bioprocessing market included the presence of large-scale manufacturing units, rising geriatric population, increasing healthcare expenditure, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global single-use bioprocessing market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Applikon Biotechnology, Boehringer Ingelheim, Cesco Bioengineering Company, Corning Inc., Danaher Corporation, Entegris, Eppendorf AG, Finesse Solutions Inc., GE Healthcare, Infors, Merck Millipore, Rentschler Biotechnologie, Sartorius Stedim Biotech, Thermo Fisher Scientific Inc., 3M Company, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.